StockData
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF

RESMED INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$239.77+0.80 (+0.33%)

Close on Oct 19, 2026

Market cap
$34.79B
P/E (TTM)
23.0
Dividend yield
1.00%

Earnings

Next report expected Oct 29, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2026
Ended Jun 30, 2026
Aug 6, 2026After market close$1.50B$2.64$2.95
Q3 FY2026
Ended Mar 31, 2026
Apr 30, 2026After market close$1.40B$2.74$2.86
Q2 FY2026
Ended Dec 31, 2025
Jan 29, 2026After market close$1.40B$2.68$2.81
Q1 FY2026
Ended Sep 30, 2025
Oct 30, 2025After market close$1.30B$2.37$2.55
Q4 FY2025
Ended Jun 30, 2025
Jul 31, 2025After market close$1.30B$2.58$2.55
Q3 FY2025
Ended Mar 31, 2025
Apr 23, 2025After market close$1.30B$2.48$2.37
Q2 FY2025
Ended Dec 31, 2024
Jan 30, 2025After market close$1.30B$2.34$2.43
Q1 FY2025
Ended Sep 30, 2024
Oct 24, 2024After market close$1.20B$2.11$2.20
Q4 FY2024
Ended Jun 30, 2024
Aug 1, 2024After market close–––
Q3 FY2024
Ended Mar 31, 2024
Apr 25, 2024After market close–––
Q2 FY2024
Ended Dec 31, 2023
Jan 24, 2024After market close–––

Company guidance

Outlook given with results on Aug 6, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
capital to be returned to shareholders through share repurchases and dividendsFY 2027$1.85BNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Resmed filed with the SEC